Epidarex Capital

Today Intuitive Ventures welcomes medtech veterans Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor. As an experienced medtech investor and operator, Burke will support the firm's growing impact in global medtech and digital health markets. She will actively collaborate with portfolio companies to advance transformative innovations addressing significant unmet clinical needs. Dr. Jaffe brings extensive experience in medical devices, diagnostics/monitoring, drug delivery, healthcare software, and venture firm management to his role advising Intuitive Ventures.? Welcome to the team! https://lnkd.in/er_UzC5m

???????? ????????????, ????: Oxford based Theolytics is leveraging a library of 100M variants of adenoviruses for a bottom up approach to oncolytic virus cancer drug development. CEO David Apelian describes the importance of choosing the right strain for the right type of cancer, and discusses the company's lead program for ovarian cancer. Full video: https://lnkd.in/guGbb9fH BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills

? Spotlight on Innovation: Connecting Life Science Investors & University Commercialization?? How do?life science investors?engage with universities to bring groundbreaking research to market??Join us for this must-attend panel discussion, moderated by Whitney Hough, Ph.D., MBA,?Director of the University of Miami’s Office of Technology Transfer. ??? March 5, 2025 ? 9:15 AM - 10:00 AM ?? Lakeside Expo Center | Room 1078 | Coral Gables, FL Featuring a powerhouse panel of industry leaders: ? J.C. Lopez, MD?– Principal, New Enterprise Associates ? Colby Kash, D.C., M.S.?– CEO, Camelot BioCapital ? Lori Gough, Ph.D.?– Partner, Epidarex Capital ? John Shire?– Co-Chair, Health Care & Life Sciences, Cozen O’Connor This discussion is essential for researchers, entrepreneurs, and investors looking to bridge the gap between discovery and commercialization.?Don’t miss out on valuable insights from?top industry experts! ?? Click here to join us & be part of the conversation!? https://lnkd.in/eeuKgfmb #SpotlightOnInnovation #LifeScience #TechTransfer #StartupFunding #UniversityOfMiami #Commercialization

Biotech innovations from NodThera ?? Newly-appointed CEO Daniel Swisher speaks to how the biotech company targets diseases attributed to chronic inflammation on #TakingStock with Trinity Chavez

Join us on Wednesday, March 5th at 8:00 AM the Lakeside Expo Center as we bring together University of Miami alumni, faculty, staff, students, and the investment community to showcase innovation initiatives at the U. Come meet the key leaders at the University driving academic innovation, mission-driven research, and commercialization programs. The event will also showcase University of Miami-related startups in various fields, including technology, life sciences, and climate resilience. Please see the agenda in the enclosed document. Registration link: https://lnkd.in/dktT-_zy "Spotlight on Innovation at University of Miami" hosted by U Innovation is organized by the University of Miami ’Cane Angel Network which brings together investors and startups from the University of Miami community of alumni, faculty, staff, students, parents of students, and friends of the U. In partnership with The Launch Pad at UM, University of Miami - Coulter Center for Translational Research, University of Miami - Office of Technology Transfer, the University of Miami Alumni Association Miami ’Canes Community, and Florida Venture Forum. Speakers: Sonja Markova, Kevin Burgoyne, Norma Kenyon, Whitney Hough, J.C. Lopez, Lori Gough, Colby Kash, John Shire, and Michael Berkowitz at University of Miami Climate Resilience Institute. Startups: 1Print, Okeanos?, Fastformulator Inc, Heru, 3rd-i Technology Inc., Material https://lnkd.in/dGx4C4t6

?????????????? ????????:?Cambridge, UK based Harness Therapeutics, which topped up its seed financing this week, aims to use its oligo platform to treat Huntington's by upregulating the FAN1 nuclease across the brain. CEO Jan Thirkettle describes the company's approach to upregulating genes for neurodegenerative diseases and how Harness is out front in targeting FAN1 for Huntington's. Full video: https://lnkd.in/gkDZUAtB BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills